×
Monday, May 6, 2024

Merck's Keytruda scores first win in adjuvant kidney cancer, giving it a leg up on checkpoint inhibitor rivals - Endpoints News

Last updated Thursday, November 18, 2021 03:00 ET , Source: NewsService